2009; 360:1946 59. 457. Pan XH, Chen YX, Xiang MX, et al. A meta-analysis of randomized trials on clinical outcomes of paclitaxel-eluting stents versus bare-metal stents in ST-segment elevation myocardial infarction patients. J Zhejiang Univ Sci B. 2010;11:754 61. 458. Hao PP, Chen YG, Wang XL, et al. Efficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarc- tion: a meta-analysis of randomized controlled trials. Tex Heart Inst J. 2010;37:516 24. 459. Suh HS, Song HJ, Choi JE, et al. Drug-eluting stents versus bare-metal stents in acute myocardial infarction: a systematic review and meta- analysis. Int J Technol Assess Health Care. 2011;27:11 22. 460. Park DW, Park SW, Park KH, et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol. 2006;98:352 6. 461. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Cir- culation. 2006;113:2803 9. 462. Nasser M, Kapeliovich M, Markiewicz W. Late thrombosis of sirolimus- eluting stents following noncardiac surgery. Catheter Cardiovasc Interv. 2005;65:516 9. 463. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496 501. 464. Serruys PW, De Jaegere P, Kiemeneij F, et al. A comparison of balloon- expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994; 331:489 95. 465. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356: 998 1008. 466. Stone GW, Midei M, Newman W, et al. 